Lauren Sabella
2014
In 2014, Lauren Sabella earned a total compensation of $1.5M as Chief Commercial Officer at Acorda Therapeutics, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $203,823 |
|---|---|
| Option Awards | $654,330 |
| Salary | $368,833 |
| Stock Awards | $236,280 |
| Other | $7,650 |
| Total | $1,470,916 |
Sabella received $654.3K in option awards, accounting for 44% of the total pay in 2014.
Sabella also received $203.8K in non-equity incentive plan, $368.8K in salary, $236.3K in stock awards and $7.7K in other compensation.
Rankings
In 2014, Lauren Sabella's compensation ranked 5,838th out of 13,032 executives tracked by ExecPay. In other words, Sabella earned more than 55.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,838 out of 13,032 | 55th |
Division Manufacturing | 2,100 out of 4,966 | 58th |
Major group Chemicals And Allied Products | 708 out of 1,686 | 58th |
Industry group Drugs | 551 out of 1,365 | 60th |
Industry Biological Products, Except Diagnostic Substances | 102 out of 236 | 57th |
Source: SEC filing on April 29, 2016.
Sabella's colleagues
We found six more compensation records of executives who worked with Lauren Sabella at Acorda Therapeutics in 2014.
2014
Andrew Hindman
Acorda Therapeutics
Chief Business Development Officer
2014
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2014
Jane Wasman
Acorda Therapeutics
General Counsel
2014
Enrique Carrazana
Acorda Therapeutics
Chief Medical Officer
2014
David Lawrence
Acorda Therapeutics
Chief, Business Operations and Principal Accounting Officer
2014
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
News
Acorda Therapeutics CEO Ron Cohen's 2022 pay falls 40% to $984K
April 27, 2023
Acorda Therapeutics CEO Ron Cohen's 2021 pay rises 9% to $1.6M
April 28, 2022
Acorda Therapeutics CEO Ron Cohen's 2020 pay falls 26% to $1.5M
April 23, 2021
Acorda Therapeutics General Counsel Jane Wasman's 2019 pay jumps 67% to $2.4M
April 28, 2020
Acorda Therapeutics CEO Ron Cohen's 2018 pay rises 20% to $2.4M
April 26, 2019